C. David Hansen
( out of 808 reviews )

C. David Hansen, MD

Languages spoken: English, German

C. David Hansen, M.D., is a dermatologist with a practice focused on the treatment of general dermatology. He has a particular emphasis in the management of acne, eczema, psoriasis, and skin cancer. After 20 years in private practice, Dr. Hansen joined the University of Utah School of Medicine faculty full-time in 1998. His research interests are in genetic skin disorders including Pachyonychia congenita. He is board certified in dermatology.

Specialties

Board Certification

American Board of Dermatology (Dermatology)

Patient Rating

Patients repeatedly praise Dr. Hansen as highly knowledgeable, skilled, and thorough in diagnosing and treating skin concerns. Reviewers emphasize his personable, caring manner—listening attentively, explaining findings and procedures clearly, easing anxiety, and sometimes using gentle humor—so they feel heard and reassured. Long-term trust, appreciation for attentive and sometimes life-saving care, and recognition of considerate, competent staff are recurring themes.

Generated via Patient Reviews

5.0 /5
( out of 808 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

C. David Hansen, M.D., is a dermatologist with a practice focused on the treatment of general dermatology. He has a particular emphasis in the management of acne, eczema, psoriasis, and skin cancer. After 20 years in private practice, Dr. Hansen joined the University of Utah School of Medicine faculty full-time in 1998. His research interests are in genetic skin disorders including Pachyonychia congenita. He is board certified in dermatology.

Board Certification and Academic Information

Academic Departments Dermatology -Professor (Clinical)
Board Certification
American Board of Dermatology (Dermatology)

Education history

Postdoctoral Training Dermatology - Massachusetts General Hospital Postdoctoral Training
Residency Dermatology - University of Michigan Resident
Internship University of Iowa Hospitals and Clinics Intern
Professional Medical Medicine - University of Utah Hospital School of Medicine M.D.
Undergraduate Chemistry - University of Utah B.S.
Undergraduate Chemistry - University of Utah

Selected Publications

Journal Article

  1. Coulombe PA, Hansen D, Hickerson R, Hovnanian A, OToole EA, Kelsell DP, Evans H, Schwartz J, Sprecher E (2024). Celebrating 20 Years of the International Pachyonychia Congenita Consortium. J Invest Dermatol, 145(4), 725-727.
  2. Schwartz JN, Evans HA, Otoole EA, Hansen CD (2023). Pachyonychia Congenita Project: Advancing Research and Drug Development through Collaboration. Keio J Med.
  3. Lipner SR, Falotico JM, Matushansky JT, Evans H, Schwartz J, Hansen CD (2022). Walking a day in a pachyonychia congenita patient's shoes: Impact on plantar pain and activity levels measured with wristband activity trackers. Indian J Dermatol Venereol Leprol, 89(6), 850-853.
  4. Pavlovsky M, Peled A, Sarig O, Astman N, Malki L, Meijers O, Assaf S, Schwartz J, Malovitski K, Hansen D, Sprecher E, Samuelov L (2022). Coexistence of pachyonychia congenita and hidradenitis suppurativa: more than a coincidence. Br J Dermatol, 187(3), 392-400.
  5. Tan XL, Thomas BR, Steele L, Schwartz J, Hansen CD, OToole EA (2022). Genotype-phenotype correlations of neurovascular structures on the feet in patients with pachyonychia congenita: A cross-sectional study. J Am Acad Dermatol.
  6. Mathews J, Hansen CD, Chandrashekar L (2020). Homozygous dominant missense mutation in Keratin 6b leading to severe pachyonychia congenita. Clin Exp Dermatol, 46(2), 410-412.
  7. Samuelov L, Sarig O, Adir N, Pavlovsky M, Smith FJ, Schwartz J, Hansen CD, Sprecher E (2021). Identification of clinically useful predictive genetic variants in pachyonychia congenita. Clin Exp Dermatol, 46, 867-873.
  8. Stewart CL, Takeshita J, Hansen CD, Rubin AI (2020). The histopathological features of the nail plate in pachyonychia congenita. J Cutan Pathol, 47(4), 357-362.
  9. Goldberg I, Mashiah J, Kutz A, Derowe A, Warshauer E, Schwartz ME, Smith F, Sprecher E, Hansen CD (2019). Symptomatic mucosal involvement in pachyonychia congenita: challenges in infants and young children. Br J Dermatol, 182(3), 708-713.
  10. Samuelov L, Smith FJD, Hansen CD, Sprecher E (2020). Revisiting pachyonychia congenita: a case-cohort study of 815 patients. Br J Dermatol, 182(3), 738-746.
  11. Han M, Wald I, Usher W, Wu Q, Wang F, Pascucci V, Hansen CD, Johnson CR (2019). Ray Tracing Generalized Tube Primitives: Method and Applications. Eurographics Workshop Vis Comput Biomed, 38(3), 467-478.
  12. Eliason MJ, Leachman SA, Feng BJ, Schwartz ME, Hansen CD (2012). A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. J Am Acad Dermatol, 67(4), 680-6.
  13. Wilson NJ, Leachman SA, Hansen CD, McMullan AC, Milstone LM, Schwartz ME, McLean WH, Hull PR, Smith FJ (2011). A large mutational study in pachyonychia congenita. J Invest Dermatol, 131(5), 1018-24.
  14. Leachman SA, Hickerson RP, Schwartz ME, Bullough EE, Hutcherson SL, Boucher KM, Hansen CD, Eliason MJ, Srivatsa GS, Kornbrust DJ, Smith FJ, McLean WI, Milstone LM, Kaspar RL (2010). First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther, 18(2), 442-6.
  15. Hansen CD (1994). Advances in the Treatment of Onychomycosis. 1-3.

Review

  1. OToole EA, Kelsell DP, Caterina MJ, de Brito M, Hansen D, Hickerson RP, Hovnanian A, Kaspar R, Lane EB, Paller AS, Schwartz J, Shroot B, Teng J, Titeux M, Coulombe PA, Sprecher E (2023). Pachyonychia Congenita: A Research Agenda Leading to New Therapeutic Approaches. [Review]. J Invest Dermatol, 144(4), 748-754.

Letter

  1. Wittmer AN, Nguyen CM, OToole E, Schwartz J, Evans H, Hansen D (2024). Non-pachyonychia congenita conditions in the International Pachyonychia Congenita Research Registry. [Letter to the editor]. Int J Dermatol, 64(7), 1285-1287.
  2. McCarthy RL, Schwartz J, Oldham J, Bodemer C, Greco C, Hovnanian A, Hansen CD, OToole EA (2024). A cross-sectional study of erythromelalgia in patients with pachyonychia congenita. [Letter to the editor]. Br J Dermatol, 191(2), 300-302.
  3. Steele L, Schwartz J, Hansen CD, OToole EA (2022). Prevalence and Characterization of Itch in Pachyonychia Congenita. [Letter to the editor]. JAMA Dermatol, 157(11), 1378-1380.
  4. Funk T, Hansen CD, Paller A, OToole EA (2019). Update on pachyonychia congenita research. [Letter to the editor]. Br J Dermatol, 182(3), 788-789.
  5. Wilson NJ, Prez ML, Vahlquist A, Schwartz ME, Hansen CD, McLean WH, Smith FJ (2012). Homozygous dominant missense mutation in keratin 17 leads to alopecia in addition to severe pachyonychia congenita. [Letter to the editor]. J Invest Dermatol, 132(7), 1921-4.